Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-03-08
2005-03-08
Richter, Johann (Department: 1626)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
active
06864373
ABSTRACT:
A process is provided for preparing a celecoxib-crystallization inhibitor composite wherein at least a detectable amount of celecoxib is in amorphous form. Also provided are compositions prepared according to such a process. Also provided is a method of treating a medical condition or disorder in a subject where treatment with a cyclooxygenase-2 inhibitor is indicated, comprising administering, for example orally, a composition of the invention in a therapeutically effective amount.
REFERENCES:
patent: 5466823 (1995-11-01), Talley et al.
patent: 5892053 (1999-04-01), Zhi et al.
patent: 6395300 (2002-05-01), Straub et al.
patent: WO 0032189 (2000-06-01), None
patent: WO 0042021 (2000-07-01), None
Lieberman et al., (1989), Pharmaceutical Dosage Forms: Tablets, vol. 1, pp. 34-36.
The Merck Index, 12thEdition, Therapeutic Category and Biological Activity Index, ed. S. Budavari (1996), pp. Ther-2 to Ther-3 and Ther-12.
Gao Ping
Zhuang Hong
Fitzsimmons Patricia K.
Pharmacia Corporation
Richter Johann
Sackey Ebenezer
LandOfFree
Stable amorphous celecoxib composite and process therefor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Stable amorphous celecoxib composite and process therefor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stable amorphous celecoxib composite and process therefor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3445412